Puga F J, Welch J S, Bisel H F
Arch Surg. 1976 Aug;111(8):877-80. doi: 10.1001/archsurg.1976.01360260045011.
Of 145 women with metastatic breast carcinoma who survived palliative surgical castration, 40.7% had objective remission and another 11.0% had subjective improvement. Favorable response was more frequent in ovulating patients who had small masses of recurrent tumor in fewer locations, with skeletal spread especially well tolerated. Palliation appeared to be related to the site of metastatic disease and numbers (mass) of metastatic sites, but not to the age of the patient, tumor histology, or the disease-free interval. Survival was better for the patients who showed improvement after castration. Such improvement may predict continued relief from the use of other modalities of systemic treatment.
在145例接受姑息性手术去势且存活的转移性乳腺癌女性患者中,40.7%有客观缓解,另有11.0%有主观改善。在排卵患者中,肿瘤复发灶较小且部位较少者更易出现良好反应,骨转移尤其耐受良好。缓解似乎与转移病灶的部位及转移灶数量(肿块)有关,而与患者年龄、肿瘤组织学类型或无病间期无关。去势后病情改善的患者生存期更长。这种改善可能预示着继续使用其他全身治疗方式也能持续缓解症状。